Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
22.88
-0.77 (-3.26%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.89 billion as of March 24, 2026. Its market cap has increased by 152.88% in one year.
Market Cap
1.89B
Enterprise Value
1.23B
1-Year Change
152.88%
Ranking
Category
Stock Price
$22.88
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.89B, an increase of 201.69%. That is a compound annual growth rate of 42.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.89B | -34.36% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 1.98B |
| Galapagos NV | 1.96B |
| Tyra Biosciences | 1.96B |
| Zai Lab | 1.93B |
| Stoke Therapeutics | 1.90B |
| Aurinia Pharmaceuticals | 1.89B |
| Enliven Therapeutics | 1.86B |
| Sarepta Therapeutics | 1.85B |